Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Oracle Corporation (ORCL.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-04-1479.4575.00Neutral
2023-03-1084.0787.00Neutral
2023-03-2488.0190.00Neutral
2023-06-06107.10110.00Neutral
2023-06-13116.68120.00Neutral
2023-08-28116.84140.00Buy
2023-09-12109.61135.00Buy
2023-12-11115.13125.00Buy
2024-03-07114.54130.00Buy
2024-03-12127.54150.00Buy
2024-06-12140.38160.00Buy
2024-09-09139.89175.00Buy
2024-09-13162.03200.00Buy
2024-12-09190.45210.00Buy
2025-03-11144.18200.00Buy
2025-06-12199.86225.00Buy
2025-06-24215.27250.00Buy

Disclosures

  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.